{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:01Z","timestamp":1791299941438,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/inf.0b013e3181ed2af3","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T06:46:38Z","timestamp":1279089998000},"page":"52-56","source":"Crossref","is-referenced-by-count":53,"title":["Long-term Outcome of Children Receiving Antiretroviral Treatment in Rural South Africa"],"prefix":"10.1097","volume":"30","author":[{"given":"Roos E.","family":"Barth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Tempelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbert","family":"Smelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie M. J.","family":"Wensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy I.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibyl P.","family":"Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20210202","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.","volume":"364","author":"Newell","year":"2004","journal-title":"Lancet"},{"key":"R3-13-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1473-3099(08)70180-4","article-title":"Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.","volume":"8","author":"Sutcliffe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R4-13-20210202","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1086\/648079","article-title":"Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.","volume":"49","author":"Ciaranello","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R9-13-20210202","first-page":"62","article-title":"Update of the drug resistance mutations in HIV-1: spring 2008.","volume":"16","author":"Johnson","year":"2008","journal-title":"Top HIV Med"},{"key":"R10-13-20210202","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","article-title":"Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.","volume":"298","author":"Bolton-Moore","year":"2007","journal-title":"JAMA"},{"key":"R11-13-20210202","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2431-8-34","article-title":"Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.","volume":"8","author":"Davies","year":"2008","journal-title":"BMC Pediatr"},{"issue":"suppl 1","key":"R12-13-20210202","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00126334-200010001-00006","article-title":"Growth failure in children with HIV infection.","volume":"25","author":"Arpadi","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-13-20210202","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/QAI.0b013e31818cdef5","article-title":"Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom\/Ireland.","volume":"49","author":"Kekitiinwa","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/apc.2007.0049","article-title":"Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda.","volume":"22","author":"Kabue","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.trstmh.2008.06.010","article-title":"Provision of antiretroviral therapy to children within the public sector of South Africa.","volume":"102","author":"Bock","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R16-13-20210202","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/00002030-200409240-00006","article-title":"Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire.","volume":"18","author":"Fassinou","year":"2004","journal-title":"AIDS"},{"key":"R17-13-20210202","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1542\/peds.2006-1122","article-title":"Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.","volume":"120","author":"Song","year":"2007","journal-title":"Pediatrics"},{"key":"R18-13-20210202","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2431-8-39","article-title":"Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center\/nurse-based care.","volume":"8","author":"van Griensven","year":"2008","journal-title":"BMC Pediatr"},{"key":"R19-13-20210202","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/QAD.0b013e328010943b","article-title":"Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.","volume":"20","author":"Rouet","year":"2006","journal-title":"AIDS"},{"key":"R20-13-20210202","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2471\/BLT.07.045294","article-title":"Antiretroviral therapy and early mortality in South Africa.","volume":"86","author":"Boulle","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R21-13-20210202","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/INF.0b013e31817acf7b","article-title":"Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.","volume":"27","author":"Jaspan","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R22-13-20210202","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1086\/595553","article-title":"Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.","volume":"48","author":"Muller","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R23-13-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1089\/aid.2007.0264","article-title":"Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Cote d'Ivoire.","volume":"24","author":"Adje-Toure","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R24-13-20210202","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.inf.0000190413.88671.92","article-title":"Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Cote d'Ivoire.","volume":"24","author":"Chaix","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R25-13-20210202","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QAI.0b013e318183acae","article-title":"High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.","volume":"49","author":"Gody","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-13-20210202","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jmv.20912","article-title":"Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.","volume":"79","author":"Lwembe","year":"2007","journal-title":"J Med Virol"},{"key":"R27-13-20210202","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1089\/aid.2008.0180","article-title":"HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.","volume":"24","author":"Pillay","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R28-13-20210202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jac\/dkp412","article-title":"Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.","volume":"65","author":"Germanaud","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"R29-13-20210202","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1097\/QAD.0b013e328313bf87","article-title":"Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa.","volume":"22","author":"Barth","year":"2008","journal-title":"AIDS"},{"key":"R30-13-20210202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa062876","article-title":"Response to antiretroviral therapy after a single, peripartum dose of nevirapine.","volume":"356","author":"Lockman","year":"2007","journal-title":"N Engl J Med"},{"key":"R31-13-20210202","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2009.0054","article-title":"Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine.","volume":"25","author":"Musiime","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R32-13-20210202","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1473-3099(09)70136-7","article-title":"Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.","volume":"9","author":"Gupta","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R33-13-20210202","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/157016208785132491","article-title":"The unique features of pediatric HIV-1 in sub-Saharan Africa.","volume":"6","author":"De Baets","year":"2008","journal-title":"Curr HIV Res"},{"key":"R34-13-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006454-200301000-00015","article-title":"Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.","volume":"22","author":"Gibb","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R35-13-20210202","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/INF.0b013e31815b1ad4","article-title":"Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa.","volume":"27","author":"Muller","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R36-13-20210202","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/600396","article-title":"Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.","volume":"49","author":"Kantor","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R37-13-20210202","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/QAD.0b013e32830e4cd8","article-title":"Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa.","volume":"22","author":"Mee","year":"2008","journal-title":"AIDS"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201101000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:28:19Z","timestamp":1786040899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201101000-00013"}},"subtitle":["Substantial Virologic Failure on First-line Treatment"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181ed2af3","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}